MDS
FDA Approves Preparative Regimen for allo-HSCT in Patients With AML or MDS
The FDA has approved treosulfan (Grafapex, medac GmbH), an alkylating agent, with fludarabine as a preparative ...
FEBRUARY 19, 2025
Rytelo Approved for Low- to Intermediate-1-Risk MDS With Transfusion-Dependent Anemia
The FDA approved imetelstat (Rytelo, Geron Corp.), an oligonucleotide telomerase inhibitor, for adults with low- to ...
JUNE 10, 2024
New Biomarker Predicts MDS Treatment Response
Researchers have identified a new biomarker to predict treatment response for myelodysplastic syndromes (MDS), ...
MARCH 22, 2022
Survival Benefit Seen From Transplant in Older Patients With Myelodysplastic Syndrome
In older patients with myelodysplastic syndrome (MDS) and a suitable HLA-matched donor, hematopoietic cell ...
JANUARY 25, 2021
FDA Approves Reblozyl to Treat Anemia in Some Patients With MDS
The FDA approved luspatercept-aamt (Reblozyl, Celgene) for the treatment of anemia in adults with very low- to ...
APRIL 10, 2020
Mayo Clinic Researchers Create Gene-Based Prognostic Model for MDS
Researchers from Mayo Clinic have developed a new risk model MDS. The genetics-based prognostic tool replaces a ...
OCTOBER 29, 2018
Understanding Why Some MDS Resists Azacitidine Treatment
Patients with myelodysplastic syndrome who are resistant to azacitidine (AZA) have quiescent bone marrow ...
NOVEMBER 6, 2017
Investigational MAB Granted Orphan Drug Status for MDS
The investigational drug BI 836858 was granted Orphan drug designation for the treatment of MDS.
MARCH 9, 2017
ASH 2016: Guillermo Garcia-Manero, MD, on Promising Clinical Data for MDS
Dr. Garcia-Manero highlighted some of the most promising clinical data presented at the 2016 ASH annual meeting.
JANUARY 24, 2017
ASH 2016: Alan List, MD, on Combined Treatment for Lower-Risk Patients With MDS
Dr. List, President of the Moffitt Cancer Center, in Tampa, Florida, sat down with Clinical Oncology News to ...
DECEMBER 19, 2016
For MDS Patients, Risk for Death or AML Changes Over Time
The longer certain groups of patients with myelodysplastic syndromes (MDS) survive, the lower their likelihood of ...
SEPTEMBER 14, 2016
Prognostic Scoring System Devised for Transplant in MDS
Orlando, Fla.—A scoring system specifically designed to predict relapse and overall survival (OS) in patients ...
MARCH 16, 2016
